Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2003-03-11
2008-09-30
Eyler, Yvonne (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C562S432000
Reexamination Certificate
active
07429677
ABSTRACT:
The present invention concerns a compound having the formula (I)a N-oxide form, a stereochemical isomer, racemic mixture, salt, prodrug, ester or metabolite thereof. It further relates to processes for their preparation as well as pharmaceutical compositions, their use as medicines, and diagnostic kits comprising them. The present invention also concerns combinations of the present entry inhibitors with anti-retroviral agents. It further relates to their use in assays as reference compounds or as reagents. The compounds of the present invention are useful for preventing or treating infection by HIV and for treating AIDS.
REFERENCES:
patent: 5571921 (1996-11-01), Bender et al.
patent: 0 628 555 (1994-12-01), None
patent: 1.557.887 (1968-01-01), None
patent: WO 91/05761 (1991-05-01), None
patent: WO 95/05170 (1995-02-01), None
patent: WO 03/004458 (2003-01-01), None
M. Hasegawa, et al., “Novel Napthalene Derivatives as Inhibitors of Human Immunoglobulin E Antibody Production”, J. Med. Chem. (1997), 40, pp. 395-407.
J. Matysiak, et al., “In vitro inhibition properties of a new group of thiobenzanilides in relation to yeasts”, European Journal of Pharmaceutical Sciences 10 (2000) 119-123.
J. Milton, et al., “Biaryl Acids: Novel Non-Nucleoside Inhibitors of HIV Reverse Transcriptase Types 1 and 2”, Bioorganic & Medicinal Chemistry Letters 8 (1998) pp. 2623-2628.
V.B. Oza, et al., “Synthesis and Evaluation of Anthranilic Acid-Based Transthyretin Amyloid Fibril Inhibitors”, Bioorganic & Medicinal Chemistry Letters 9 (1999) pp. 1-6.
A. Varnavas, et al., “Anthranoyl-anthranilic acid: a template for the development of a new class of cholecystokinin receptor ligands”, Pharmazie 51 (1996) pp. 697-700.
De Bethune Marie-Pierre T. M. M. G
De Meyer Sandra
Eissenstat Michael
Hertogs Kurt
Lu Rong Jian
Cho Jennifer Y
Eyler Yvonne
Tibotec Pharmaceuticals Ltd.
LandOfFree
Small molecule entry inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small molecule entry inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule entry inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3987765